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Abstract
 
In addition to their CD1d-restricted T cell receptor (TCR), natural killer T (NKT) cells express
various receptors normally associated with NK cells thought to act, in part, as modulators of
TCR signaling. Immunoreceptor-tyrosine activation (ITAM) and inhibition (ITIM) motifs asso-
ciated with NK receptors may augment or attenuate perceived TCR signals respectively, poten-
tially influencing NKT cell development and function. ITIM-containing Ly49 family receptors
expressed by NKT cells are proposed to play a role in their development and function. We have
produced mice transgenic for the ITAM-associated Ly49D and ITIM-containing Ly49A recep-
tors and their common ligand H2-D
 
d
 
 to determine the importance of these signaling interplays
in NKT cell development. Ly49D/H2-D
 
d
 
 transgenic mice had selectively and severely reduced
numbers of thymic and peripheral NKT cells, whereas both ligand and Ly49D transgenics had
normal numbers of NKT cells. CD1d tetramer staining revealed a blockade of NKT cell devel-
opment at an early precursor stage. Coexpression of a Ly49A transgene partially rescued NKT
cell development in Ly49D/H2-D
 
d
 
 transgenics, presumably due to attenuation of ITAM signal-
ing. Thus, Ly49D-induced ITAM signaling is incompatible with the early development of cells
expressing semi-invariant CD1d-restricted TCRs and appropriately harmonized ITIM–ITAM
signaling is likely to play an important role in the developmental program of NKT cells.
Key words: NKT cell development • ITAM-containing receptors • ITIM-containing receptors • 
TCR repertoire • NK receptor repertoire
 
Introduction
 
Murine natural killer T (NKT) cells may be defined as T
cells expressing diverse inhibitory and activating receptors
normally found on NK cells as well as an 
 

 
TCR selected
for reactivity to CD1d, a nonpolymorphic MHC Ib mole-
cule (1, 2). Activated NKT cells rapidly produce cytokines
capable of influencing a wide variety of innate and adaptive
immune responses. CD1d-restricted NKT cells express a
very limited, “semi-invariant,” TCR repertoire. In the
mouse, this consists of a germline-encoded V
 

 
14–J
 

 
18
chain paired with 
 

 
 chains containing a small range of V
 

 
segments, the most commonly used being V
 

 
8.2 (3). One
widely held hypothesis is that this TCR repertoire special-
izes in the recognition of self-lipid antigens in contexts
where their presentation is aberrant. The development of
NKT cells would thus require the selection of a potentially
autoreactive TCR repertoire, accompanied by the estab-
lishment of tight controls upon this autoreactivity in the
mature population.
Expression of MHC class I-specific inhibitory receptors
by NKT cells and subsets of T cells provides a possible
mechanism for regulating perceived TCR signals (4). Mu-
rine NKT cells express many members of the Ly49 family
of lectin-like receptors which recognize H2-encoded
ligands (5) and Ly49 ligation influences NKT cell respon-
siveness to antigen (6, 7). Ly49 family receptors exist in
inhibitory and activating forms that signal through
immunoreceptor-tyrosine inhibition motifs (ITIMs) and
immunoreceptor-tyrosine activation motifs (ITAMs) re-
spectively. Ligated inhibitory Ly49 receptors, such as
Ly49A, recruit and activate SH2-domain containing phos-
phatases, whereas Ly49D and other activating Ly49 recep-
tors form complexes with an ITAM-containing signaling
subunit, DAP12 (8). Upon ligation of its associated recep-
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tor, DAP12 mediates recruitment and phosphorylation of
the 
 
syk
 
 and ZAP 70 kinases. As phosphorylated ZAP 70 is
an important participant in the TCR/CD3 signaling cas-
cade, ITAM-mediated signaling by activating Ly49 recep-
tors could have additive effects on TCR signaling. Curi-
ously however, expression of Ly49D and Ly49H, the only
activating Ly49 receptors for which specific antibodies are
available, is not detected on CD3
 

 
 cells (9–11). This might
indicate a general lack of activating Ly49 receptor expres-
sion on T and NKT cells, a situation which would raise the
possibility that activating (but not inhibitory) Ly49 signal-
ing is in some way specifically incompatible with T/NKT
cell development and/or function.
Transgenic expression of inhibitory Ly49 receptors on T
and NKT cells has provided much insight into possible
roles for Ly49 signaling in T and NKT cell selection and
development. Studies of mice expressing transgenic Ly49A
on thymocytes have demonstrated the ability of inhibitory
Ly49 signaling to affect the outcome of positive and nega-
tive selection of T cells (12, 13). Other Ly49A transgenic
mice exhibit a defect late in the development of NKT cells
(14). While these mice have near normal numbers of thy-
mic V
 

 
8.2
 

 
 (i.e., CD1d-restricted) NKT cells, numbers of
hepatic V
 

 
8.2
 

 
 NKT cells are significantly reduced in a
ligand-dependent fashion.
These studies of Ly49A transgenic mice as well as in vitro
studies indicating a role for Ly49 signaling in regulating NKT
cell responses (6, 7), indicate that Ly49 expression may influ-
ence NKT cell development. To investigate the effects of ac-
tivating Ly49 signaling on the selection and development of
CD1d-restricted NKT cells, we created transgenic mice co-
expressing Ly49D and its associated DAP12 signaling sub-
unit. Ligation of this transgenic receptor complex is predicted
to induce ITAM signaling, thereby adding to the TCR sig-
nals perceived by developing NKT cells. We report here that
mice expressing a transgenic Ly49D receptor complex and
H2-D
 
d
 
, one of its ligands, have a selective defect in the gen-
eration of CD1d-restricted NKT cells that can be partially
reversed by concomitant inhibitory Ly49A signaling.
 
Materials and Methods
 
Preparation of Transgenic Mice.
 
A Ly49D cDNA identical to
that previously described (GenBank/EMBL/DDBJ accession
no. U10090) was isolated by RT-PCR using the primers
AATA
 
GTCGA
 
50
 
C TCTACATACTCCCGAGATG and AAT
 
A-
GATCT
 
 A
 
863
 
CTCACTGGAGAGTCAATG (italics indicate re-
striction sites added to facilitate cloning, numbers indicate nucle-
otide positions in the Ly49D sequence). SalI, BglII-cut PCR
product was ligated into SalI, BamHI-cut H2-Kb promoter/Ig en-
hancer expression cassette (15). A murine DAP12 cDNA identical
to that reported previously (GenBank/EMBL/DDBJ accession
no. AF024637) was obtained by RT-PCR using the primers
CG
 
GAATTCC
 
ACCA
 
1
 
TGGGGCTCTGGAGCCCTCC and
CG
 
GAATTC
 
T
 
345
 
CATCTGTAATATTGCCTCTG. A DAP12
cDNA was isolated from the plasmid containing the cloned PCR
product as an XhoI, BamHI fragment and ligated into SalI, BamHI-
cut expression cassette. Double transgenic mice were generated by
coinjection of Ly49D and DAP12 constructs into (C57BL/6 
 

 
DBA/2)F
 
2
 
 eggs. Founders were identified by Southern blotting and
expression of transgenic Ly49D was confirmed by FACS
 
®
 
 analysis
of PBL. Expression of the DAP12 transgene in PBL was verified by
RT-PCR using the 5
 

 
 primer shown above and a 3
 

 
 transgene-
specific primer CTGGTGGGGTGAATTCTTTGCC. Founders
were backcrossed to C57BL/6 at least six times.
C57BL/6 and DBA/2 mice were obtained from Harlan.
C57BL/6 mice transgenic for Ly49A (line #2; reference 16) and
for a large genomic fragment of H2-D
 
d
 
 (17) have been described
previously.
 
DAP12 Expression Analysis.
 
cDNA was prepared from 10
 
5
 
sorted thymocytes or liver mononuclear cells by standard meth-
ods. DAP12 transcripts were amplified using the exon-span-
ning primers 
 
70
 
CCGTACAGGCCCAGAGTG and 
 
224
 
CTTGA-
CCTCGGGAGACCAG. 
 

 
2-microglubulin transcripts were
amplified using the primers: GTGTATGCTATCCAGAA-
AACCC and TCACATGTCTCGATCCCAGTAG. Cycling
conditions for both primer pairs were: 95
 

 
C for 3 min, then 40
cycles of 94
 

 
C for 30 s, 60
 

 
C for 30 s, 72
 

 
C 40 s, then 72
 

 
C for
10 min.
 
Cell Preparation.
 
Nylon wool nonadherent spleen and bone
marrow cells were isolated as described previously (18). Liver
mononuclear cells were prepared on 40/70% percoll gradients by
standard methods (18). Erythrocytes in spleen, bone marrow, and
liver cell preparations were lysed using 0.83% ammonium chlo-
ride solution before FACS
 
®
 
 analysis. HSA-/CD8-depleted thy-
mocytes were prepared using hybridoma supernatants 3.168.8.1
(anti-CD8
 

 
) and B2A2 (anti-HSA) followed by treatment with
rabbit complement and purification on a Lympholyte M (Cedar-
lane) gradient as described previously (19).
 
Antibodies and Flow Cytometry.
 
mAb conjugates purchased
from BD Biosciences were: Ly49D-FITC (4E5), 
 
	
 
TCR-FITC
(GL3), NK1.1-PE and -biotin (PK136), TCR
 

 
-Cychrome
(H57–597). CD4-APC (RM4–5) was purchased from eBio-
science. mAb conjugates produced at our institute were: CD44-
FITC (1M.781), V
 

 
8.2-biotin (F23.2). Streptavidin–APC was
purchased from Molecular Probes. Murine CD1d tetramers com-
plexed using PE-streptavidin and loaded (or not) with 
 

 
-galacto-
syl–ceramide were a kind gift of Dr. Mitchell Kronenberg (La
Jolla Institute for Allergy and Immunology, La Jolla, CA). Tet-
ramer stainings were performed before other staining steps as rec-
ommended (20). Blockage of Fc receptors with the hybridoma
supernatant 2.4G2, antibody staining of cells and FACS
 
®
 
 analysis
were performed as described previously (18).
 
Results and Discussion
 
Although Ly49D may be capable of associating with and
signaling via CD3
 


 
 (21), the DAP12 signaling subunit is es-
sential for the function and efficient surface expression of
Ly49D on NK cells (22). As DAP12 does not appear to be
expressed to any significant extent by CD4
 

 
 CD8
 

 
 (DP)
thymocytes, NKT, or T cells from normal C57BL/6 mice
(Fig. 1 C), we created mice doubly transgenic for Ly49D
and DAP12 to ensure optimal Ly49D signaling activity.
Coinjection of constructs using the same H2-K
 
b
 
 promoter/
Ig enhancer expression cassette (Fig. 1 A; reference 15)
produced three founders that had cointegrated both con-
structs and expressed transgenic Ly49D. These were back-
crossed six or more times to C57BL/6 mice. Each line was
then crossed with C57BL/6 mice transgenic for a large ge-
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nomic fragment of the H2-D
 
d
 
 gene (17). Regulation of
H2-D
 
d
 
 expression in these transgenic mice is comparable in
all respects examined to that of the endogenous H2-D
 
d
 
gene in H2
 
d
 
 mice (17, and unpublished data). Use of these
H2-D
 
d
 
 transgenic mice permitted the physiological expres-
sion of a single, defined Ly49D ligand on an otherwise ge-
netically identical C57BL/6 background. For simplicity,
Ly49D/DAP12 double transgenic mice are hereafter re-
ferred to as being “Ly49D transgenic.”
All three transgenic lines expressed Ly49D on all thy-
mocytes from the CD4
 

 
, CD8
 

 
, CD25
 

 
 (DN3) stage on-
ward (unpublished data). The levels of Ly49D expressed by
mature NKT, T and NK cells were examined in all three
transgenic lines (Fig. 1 B, Table I, and unpublished data).
Levels of transgenic Ly49D expression were highest on NK
cells but were still comparable to endogenous Ly49D levels
on NK cells in littermate mice. T cells and NKT cells both
showed lower levels of transgene expression, with NKT
cells expressing less Ly49D than T cells in all tissues exam-
ined. Analysis of DAP12 transgene expression in DP thy-
mocytes, NKT and T cells by RT-PCR determined that
levels of transgenic DAP12 transcripts expressed by these
populations were similar to, although somewhat lower
than, the levels of endogenous DAP12 transcripts expressed
by NK cells (Fig. 1 C).
Examination of Ly49D 
 

 
 H2-D
 
d
 
 transgenic intercross
progeny revealed that Ly49D/H2-D
 
d
 
 transgenic mice had
smaller thymi and fewer peripheral T cells than littermate
mice of other genotypes. The reduction in thymic cellular-
ity was approximately fivefold (Fig. 2 B) and numbers of
peripheral 
 

 
T cells were reduced about threefold (Fig. 2,
A and B). Strongly reduced thymocyte numbers were first
seen at the DP stage (unpublished data). The nature of this
general T cell developmental phenotype is being examined
and will be reported elsewhere.
When NKT cell numbers in the thymi and peripheral
tissues of these transgenic intercross progeny were assessed
by NK1.1, TCR
 

 
 double staining, a striking reduction in
the proportion of 
 

 
NKT cells present in Ly49D/H2-D
 
d
 
transgenic mice was noted in all organs examined (Fig. 2
A). Thus, absolute numbers of NK1.1
 

 
, TCR
 

 

 
 cells were
reduced by 10-fold in the thymus and 32-fold in the liver
when compared with Ly49D or H2-D
 
d
 
 transgenic mice
(Fig. 2 B). The presence of normal numbers of NK1.1
 

 
,
TCR
 

 

 
 cells in both Ly49D and H2-D
 
d
 
 transgenic mice
suggested that this reduction depended upon ligation of the
Ly49D/DAP12 complex by H2-D
 
d
 
. In the thymi of
Ly49D/H2-D
 
d
 
 transgenic mice, a large population of
NK1.1
 

 
, TCR
 

 
–
 
 cells was evident (Fig. 2 A). These were
found to be 
 
	
 
TCR
 

 
 NKT cells (unpublished data), a
Figure 1. Transgene expression in Ly49D/DAP12 transgenic (“Ly49D
transgenic”) mice. (A) Schematic of coinjected transgene expression con-
structs. (B) Ly49D expression on thymic NKT, T, and splenic NK cells.
Expression in nontransgenic littermate (unfilled histogram) and Ly49D
transgenic (filled histogram) mice is shown. NKT cells are gated as
NK1.1, TCRInt, T cells are gated as NK1.1, TCRHi, and NK cells
as NK1.1, TCR, 	TCR. (C) RT-PCR analysis of DAP12 and
control -2 microglobulin (-2M) transcript expression by sorted cell
populations (DP thymocytes were gated as CD4, CD8, TCRLo,
other populations were gated as above) from nontransgenic littermate
(LM) and Ly49D transgenic (Tg) mice. The cDNA was used neat, as well
as diluted 10-fold and 100-fold to titrate expression levels. The undiluted
cDNA reactions contained 5  103 cell equivalents from a cDNA pool
synthesized from 105 cells.
 
Table I.
 
Transgenic and Endogenous Ly49D Expression on 
NKT, T, and NK Cells
 
NKT cells
 
a
 
T cells
 
b
 
NK cells
Ly49Dtg 18 
 
 
 
5 78 
 
 
 
10 126 
 
 
 
23
 
c
 
Ly49D/H2-D
 
d
 
tg 14 
 
 2 25  8 108  28c
H2-Ddtg 6  1 4  1 134  4d
C57BL/6 6  1 4  1 142  3d
Transgenic and endogenous Ly49D expression is expressed as mean
fluorescence intensity  SD.
aGated as NK1.1, TCRInt thymocytes.
bGated as NK1.1, TCRHi thymocytes.
cGated as NK1.1, TCR, 	TCR splenocytes.
dGated as Ly49D (endogenously expressed), NK1.1, TCR,
	TCR splenocytes.
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population of cells which also expands in CD1d-deficient
mice (unpublished data) and other mice with defects in
CD1d-restricted NKT cell development (23).
Mice derived from all three Ly49D transgenic lines dis-
played similar phenotypes with respect to NKT and T cell
development when crossed to H2-Dd transgenic mice (un-
published data). H2-Dd molecules expressed from the en-
dogenous gene also selectively impaired NKT cell develop-
ment in Ly49D transgenic mice since NKT cell
numbers in Ly49D transgenic B6:DBA/2 F1 offspring
were reduced to levels similar to those found in Ly49D/
H2-Dd transgenic mice (unpublished data).
Murine CD1d-restricted NKT cells most commonly uti-
lize V8.2 in the TCR chain that pairs with V14-J18
(3). V8.2 expression in an NK1.1, TCR population is
thus a useful indicator of CD1d specificity. Proportions of
NKT cells expressing V8.2 were also reduced approxi-
mately twofold, from 48  5% to 21  6% (see also Fig. 4
B), in the thymi of Ly49D/H2-Dd transgenic mice and ab-
solute numbers were reduced 50-fold in thymus and liver
(Fig. 2 B). This reduction in numbers of V8.2 cells was
selective for NKT cells since the proportion of V8.2
cells among NK1.1 conventional T cells in Ly49D/
H2-Dd transgenic mice was unaffected (unpublished data
and see Fig. 4 B) and their numbers were not selectively re-
duced (Fig. 2 B). The few NK1.1, TCR cells found in
Ly49D/H2-Dd transgenic mice thus had a significantly dif-
ferent TCR repertoire to NK1.1, TCR cells found in
Ly49D or H2-Dd transgenic mice, suggesting that develop-
ment of NKT cells expressing semiinvariant CD1d-
restricted TCRs was selectively impaired.
Little is known of the origin and functional significance
of the CD1d-independent NKT cell population which ex-
presses a diverse TCR repertoire and is particularly abun-
dant in the bone marrow and spleen (18). It is noteworthy,
however, that this population was also less abundant in
Ly49D/H2-Dd transgenic mice since absolute numbers of
NK1.1, TCR cells were reduced in bone marrow and
spleen by significantly more than the 30–40% that would
be expected (20, 24) if only the CD1d-dependent NKT
cells in these tissues were affected (Fig. 2 A). Proportions of
V8.2 cells among residual NK1.1 T cells in Ly49D/
H2-Dd transgenic mice were, nonetheless, severely reduced
(12  2% in bone marrow and 10  3% in spleen, com-
pared with 22  3% and 33  2% in the same tissues of
Ly49D transgenic littermates). This suggested that the de-
velopment of the CD1d-dependent NKT cell population
was most severely affected in these tissues.
To directly confirm that CD1d-restricted NKT cells
were selectively reduced in number in Ly49D/H2-Dd
transgenic mice, we used multimeric CD1d complexes
loaded with the artificial NKT cell ligand -galactosyl-
ceramide (reference 20; hereafter referred to as “tetra-
mers”) to detect cells expressing CD1d-restricted TCRs.
Whereas normal numbers of tetramer positive thymocytes
were found in Ly49D transgenic and H2-Dd transgenic
mice, very few tetramer positive cells were found in
Ly49D/H2-Dd transgenic thymi (numerically 30-fold
fewer; Fig. 3 A). Greatly reduced numbers of tetramer pos-
itive cells were also noted in the livers of Ly49D/H2-Dd
transgenic mice (Fig. 3 B). Thus, there was a dramatic re-
duction in the numbers of CD1d-restricted NKT cells in
Ly49D/H2-Dd transgenic mice that was of a similar order
to that seen for NK1.1, TCR, V8.2 cells.
Recent studies have identified proliferating immediate
precursors of NKT cells as tetramer positive cells lacking
surface expression of NK1.1 that are most evident in the
first few weeks after birth (25–27). The first tetramer posi-
tive cells to appear in young mice have been reported to be
predominantly CD4 and to express low or intermediate
levels of CD44. Residual tetramer positive thymocytes in
young Ly49D/H2-Dd transgenic mice were mostly CD4
NK1.1 and a larger proportion of them were CD44 low
or intermediate (Fig. 3 A), whereas tetramer positive thy-
mocytes in Ly49D and H2-Dd transgenic mice were a mix-
ture of CD4, CD8– and CD4 cells that were proportion-
ately more NK1.1 and CD44Hi (Fig. 3 A). This suggests
Figure 2. Selective impairment of NKT cell development in Ly49D
transgenic mice is ligand-dependent. (A) FACS® analysis of NKT cells
in various tissues of nontransgenic littermate, Ly49D transgenic and
Ly49D/H2-Dd transgenic mice. Contour plots are gated on lymphoid
cells among nylon wool nonadherent cells from bone marrow and spleen,
among lymphoid-gated liver mononuclear cells, and among viable un-
treated thymocytes. (B) Histograms showing absolute numbers of thymic
and hepatic T and NKT cells in Ly49D transgenic (shaded bars) and
Ly49D/H2-Dd transgenic (unfilled bars) mice with standard deviations
calculated from three independent experiments. Approximate fold reduc-
tions of cell numbers in Ly49D/H2-Dd transgenic mice are also indicated.
All mice used were 5 wk old.
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that the few tetramer positive cells present in young
Ly49D/H2-Dd transgenic thymi are more immature than
the tetramer positive cells found in littermate thymi. The
strong overall reduction in numbers of NKT cell precursors
indicates that the blockade of NKT cell development in
Ly49D/H2-Dd transgenic mice is first manifest at a very
early stage, during establishment of the precursor pool.
This blockade, while severe, is not absolute and develop-
ment of small numbers of NKT precursors still occurs.
However, these immature precursors would seem to
progress and/or expand less efficiently during their subse-
quent development since proportions of mature phenotype
NKT cells are selectively reduced (Fig. 3 A).
To study the signaling interactions between activating and
inhibitory Ly49 receptors expressed on NKT and T cells,
we crossed Ly49D transgenic mice with Ly49A transgenic
mice. Ly49A expression in these transgenic mice is directed
by the same H2-Kb/Ig enhancer expression cassette used to
generate Ly49D transgenic mice and all T and NKT cells
express Ly49A (14, 16). As H2-Dd is a ligand of both Ly49A
and Ly49D, intercrossing of the Ly49A, Ly49D, and H2-Dd
transgenic lines provides a genetically well defined in vivo
model to study this signaling interplay. Expression levels of the
Ly49D and H2-Dd transgenes were found to be equivalent on
NKT and other hematopoietic cell populations of these inter-
cross mice (unpublished data). Interestingly, mice transgenic
for Ly49A/Ly49D/H2-Dd had a population of NK1.1,
TCR thymocytes, six times larger than that of Ly49D/
H2-Dd transgenic littermates (Fig. 4 A). Mice of all other ge-
notypes had normal numbers of NK1.1, TCR thy-
mocytes. Ly49A/Ly49D/H2-Dd transgenic mice also had an
increased proportion of V8.2, NK1.1, TCR thy-
mocytes: (34%), compared with Ly49D/H2-Dd transgenic
mice (22%; Fig. 4 B). Proportions of V8.2, NK1.1–,
TCR mature thymic T cells, however, remained constant
in mice of all genotypes (Fig. 4 B). This suggests that V8.2,
CD1d-restricted NKT cells are being rescued by Ly49A-medi-
ated inhibition of Ly49D and/or TCR signaling. Despite the
apparent dominance of ITIM signaling (21), numbers of NKT
cells found in Ly49A/Ly49D/H2-Dd transgenic mice were not
increased to levels comparable to those found in Ly49A/
H2-Dd transgenic mice, perhaps in part because the restoration
of thymic cellularity was only partial (unpublished data).
Collectively, our data suggest that the development of
CD1d-restricted NKT cells depends critically on the level of
ITAM (i.e., TCR) signaling perceived by very early NKT
precursors, as additional ITAM signaling by activating Ly49
receptors appears to interfere with establishment of the early
precursor pool and impede their subsequent development.
These findings are consistent with instructive models of
NKT cell development where a common T/NKT cell pre-
cursor is recruited to the NKT lineage by expression of a
TCR with a specific affinity range for CD1d (perceived pri-
marily as a specific level of ITAM signaling). Other recent
support for an instructive model of NKT cell development
comes from the observation that intrathymic injection of DP
thymocytes generates NKT cells in a CD1d-dependent fash-
ion (28). It is thus possible that the primary blockade of
NKT cell development in Ly49D/H2-Dd transgenic mice
occurs at a DP precursor stage. It has been proposed that the
semi-invariant TCRs expressed by NKT cells have intrinsi-
cally high affinities for self-ligands presented by CD1d that
may approach or even exceed the affinity thresholds prompt-
ing negative selection of mainstream T cells (1). In this
scenario, DP cells expressing a limited range of CD1d-
restricted TCRs (3) would be exquisitely sensitive to nega-
tive selection due to additional ITAM-signaling provoked by
Ly49D ligation. The selective loss of V8.2 NKT cells seen
in our system might therefore indicate that the V14/V8.2
TCRs have a relatively higher affinity for CD1d complexed
with self-ligand when compared with other CD1d-restricted
TCRs. Alternatively or additionally, excessive ITAM signal-
ing could interfere with differentiation and expansion of
early NKT cell precursors, as would be suggested by the
higher proportions of immature NKT precursors seen in
Ly49D/H2-Dd transgenic thymi. In any case, the selective
loss of CD1d-restricted NKT cells seen in our study would
seem to result from a failure to satisfy specific signaling crite-
ria dictated by their unique developmental program.
Figure 3. Early impairment of CD1d-restricted NKT precursor devel-
opment in Ly49D/H2-Dd transgenic mice. (A) Thymocytes from 5-wk-
old H2-Dd transgenic, Ly49D transgenic, and Ly49D/H2-Dd transgenic
mice were enriched for NKT cells and precursors by treatment with anti-
CD8, anti-HSA, and complement. Top panels show staining of viable
cells with -galactosyl-ceramide loaded mouse CD1d tetramers (CD1d
Tet.) and CD4. Bottom panels show staining of tetramer positive cells
(gated as indicated) for CD44 and NK1.1. Background staining of CD8-/
HSA-depleted thymocytes with tetramers that had not been loaded with
-galactosyl-ceramide was negligible (unpublished data). (B) Staining of
gated TCR liver mononuclear cells from the mice in panel A for tetra-
mers and CD4. Data from one of two similar experiments are shown.
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Based on our data and those obtained by others with
Ly49A transgenic mice (12, 13, 29), ITAM- and ITIM-
mediated signaling by Ly49 family molecules can have com-
peting positive and negative effects on TCR signaling during
thymocyte development. The detrimental effects of Ly49D
signaling on NKT cell development are counteracted by co-
expression of Ly49A, probably as a consequence of diminu-
tion of the perceived ITAM (Ly49D/TCR) signal by coacti-
vation of the Ly49A ITIM. This might free cells expressing
CD1d-restricted TCRs from the constraints upon their early
development imposed by excessive ITAM signaling. If this is
the case, it might have been expected that substantial num-
bers of Ly49D/H2-Dd transgenic NKT cells would be res-
cued in this way by endogenous expression of Ly49A and
other inhibitory receptors specific for H2-Dd. However,
there may have been no opportunity for this to occur since
endogenous inhibitory Ly49 receptors are not expressed un-
til the later stages of NKT cell development (25, 28).
Regulated expression of inhibitory NK cell-associated re-
ceptors, including Ly49 family members, plays a crucial role
in controlling the development, maturation, and responsive-
ness of CD1d restricted NKT cells (6, 7, 14, 25–27). It is be-
coming apparent that NKT cells are subject to a particular
and elaborate developmental program depending upon spe-
cific, balanced signaling outcomes. This program is likely to
involve positive selection of rare DP precursors expressing
semi-invariant, CD1d-restricted TCRs followed by their ex-
pansion and maturation into cells with potential self-reactiv-
ity, which may be partly counteracted by expression of in-
hibitory Ly49 receptors (6, 7). The deleterious effects of
Ly49D signaling on NKT cell development reported here
underline the importance of timely and appropriate NK re-
ceptor acquisition in this program. NK cells are known to
undergo a step-wise program of receptor expression that
plays an important role in their development, tolerance, and
functional specification (5, 30). It now seems increasingly
likely that NKT cells undergo a similar finely-orchestrated
program of NK receptor acquisition which might also be
critical for their selection, expansion, tolerance, and function.
We are grateful to Dr. Mitchell Kronenberg for his kind gift of mu-
rine CD1d tetramers. We thank Drs. Anne Wilson and Isabel Fer-
rero for many helpful discussions. Dr. Bente Lowin-Kropf is grate-
fully acknowledged for her gift of a murine DAP12 cDNA.
This work was supported in part by a grant (RG-00168/2000) to
H.R. MacDonald from the Human Frontier Science Program. W. Held
received grant support from the Swiss National Science Foundation.
Submitted: 12 September 2002
Revised: 3 February 2003
Accepted: 3 February 2003
Figure 4. Partial rescue of NKT cell development in
Ly49D/H2-Dd transgenic mice by a Ly49A transgene. (A)
Thymocytes stained for NK1.1 and TCR from 9-wk-old
mice expressing the indicated transgenes (top panels, mice
on C57BL/6 background; bottom panels, mice on H2-Dd
transgenic C57BL/6 background). The percentages of cells
in the upper two quadrants are indicated with correspond-
ing absolute numbers (in thousands) of cells per thymus in
brackets. In Ly49D/H2-Dd and Ly49A/Ly49D/H2-Dd
transgenic thymi, cells in the top left quadrants are pre-
dominantly 	TCR NKT cells (unpublished data). (B)
Percentages of V8.2 NKT and T cells in the thymi of
mice in panel A. Gating is as for Fig. 1 B. Representative
data from one of three similar experiments are shown.
 o
n
 July 22, 2008 
w
w
w
.jem.org
D
ow
nloaded from
 
 Published April 7, 2003
T
h
e 
Jo
u
rn
al
 o
f 
E
xp
er
im
en
ta
l 
M
ed
ic
in
e
925 Voyle et al. Brief Definitive Report
References
1. Bendelac, A., M. Bonneville, and J.F. Kearney. 2001. Au-
toreactivity by design: innate B and T lymphocytes. Nat.
Rev. Immunol. 1:177–186.
2. Kronenberg, M., and L. Gapin. 2002. The unconventional
lifestyle of NKT Cells. Nat. Rev. Immunol. 2:557–568.
3. Park, S.H., A. Weiss, K. Benlagha, T. Kyin, L. Teyton, and
A. Bendelac. 2001. The mouse CD1d-restricted repertoire is
dominated by a few autoreactive T cell receptor families. J.
Exp. Med. 193:893–904.
4. Ugolini, S., and E. Vivier. 2000. Regulation of T cell func-
tion by NK cell receptors for classical MHC class I molecules.
Curr. Opin. Immunol. 12:295–300.
5. Raulet, D.H., R.E. Vance, and C.W. McMahon. 2001.
Regulation of the natural killer cell receptor repertoire.
Annu. Rev. Immunol. 19:291–330.
6. Ikarashi, Y., R. Mikami, A. Bendelac, M. Terme, N.
Chaput, M. Terada, T. Tursz, E. Angevin, F.A. Lemonnier,
H. Wakasugi, and L. Zitvogel. 2001. Dendritic cell matura-
tion overrules H-2D-mediated natural killer T (NKT) cell
inhibition: critical role for B7 in CD1d-dependent NKT cell
interferon gamma production. J. Exp. Med. 194:1179–1186.
7. Maeda, M., S. Lohwasser, T. Yamamura, and F. Takei. 2001.
Regulation of NKT cells by Ly49: analysis of primary NKT
cells and generation of NKT cell line. J. Immunol. 167:4180–
4186.
8. Lanier, L.L., and A.B. Bakker. 2000. The ITAM-bearing
transmembrane adaptor DAP12 in lymphoid and myeloid
cell function. Immunol. Today. 21:611–614.
9. Ortaldo, J.R., R. Winkler-Pickett, A.T. Mason, and L.H.
Mason. 1998. The Ly-49 family: regulation of cytotoxicity
and cytokine production in murine CD3 cells. J. Immunol.
160:1158–1165.
10. Smith, H.R., H.H. Chuang, L.L. Wang, M. Salcedo, J.W.
Heusel, and W.M. Yokoyama. 2000. Nonstochastic coex-
pression of activation receptors on murine natural killer cells.
J. Exp. Med. 191:1341–1354.
11. Lees, R.K., I. Ferrero, and H.R. MacDonald. 2001. Tissue-
specific segregation of TCRgamma delta NKT cells ac-
cording to phenotype TCR repertoire and activation status:
parallels with TCR alphabetaNKT cells. Eur. J. Immunol.
31:2901–2909.
12. Pauza, M., K.M. Smith, H. Neal, C. Reilly, L.L. Lanier, and
D. Lo. 2000. Transgenic expression of Ly-49A in thymocytes
alters repertoire selection. J. Immunol. 164:884–892.
13. Fahlen, L., L. Oberg, T. Brannstrom, N.K. Khoo, U.
Lendahl, and C.L. Sentman. 2000. Ly49A expression on T
cells alters T cell selection. Int. Immunol. 12:215–222.
14. MacDonald, H.R., R.K. Lees, and W. Held. 1998. Develop-
mentally regulated extinction of Ly-49 receptor expression
permits maturation and selection of NK1.1 T cells. J. Exp.
Med. 187:2109–2114.
15. Pircher, H., T.W. Mak, R. Lang, W. Ballhausen, E. Ruedi,
H. Hengartner, R.M. Zinkernagel, and K. Burki. 1989. T
cell tolerance to Mlsa encoded antigens in T cell receptor V
beta 8.1 chain transgenic mice. EMBO J. 8:719–727.
16. Held, W., D. Cado, and D.H. Raulet. 1996. Transgenic ex-
pression of the Ly49A natural killer cell receptor confers class
I major histocompatibility complex (MHC)-specific inhibi-
tion and prevents bone marrow allograft rejection. J. Exp.
Med. 184:2037–2041.
17. Ioannidis, V., J. Zimmer, F. Beermann, and W. Held. 2001.
Cre recombinase-mediated inactivation of H-2Dd transgene
expression: evidence for partial missing self-recognition by
Ly49A NK cells. J. Immunol. 167:6256–6262.
18. Eberl, G., R. Lees, S.T. Smiley, M. Taniguchi, M.J. Grusby,
and H.R. MacDonald. 1999. Tissue-specific segregation of
CD1d-dependent and CD1d-independent NKT cells. J. Im-
munol. 162:6410–6419.
19. Wolfer, A., T. Bakker, A. Wilson, M. Nicolas, V. Ioannidis,
D.R. Littman, P.P. Lee, C.B. Wilson, W. Held, H.R. Mac-
Donald, and F. Radtke. 2001. Inactivation of Notch 1 in im-
mature thymocytes does not perturb CD4 or CD8T cell de-
velopment. Nat. Immunol. 2:235–241.
20. Matsuda, J.L., O.V. Naidenko, L. Gapin, T. Nakayama, M.
Taniguchi, C.R. Wang, Y. Koezuka, and M. Kronenberg.
2000. Tracking the response of natural killer T cells to a gly-
colipid antigen using CD1d tetramers. J. Exp. Med. 192:741–
754.
21. Ortaldo, J.R., R. Winkler-Pickett, J. Willette-Brown, R.L.
Wange, S.K. Anderson, G.J. Palumbo, L.H. Mason, and
D.W. McVicar. 1999. Structure/function relationship of acti-
vating Ly-49D and inhibitory Ly-49G2 NK receptors. J. Im-
munol. 163:5269–5277.
22. Bakker, A.B., R.M. Hoek, A. Cerwenka, B. Blom, L. Lu-
cian, T. McNeil, R. Murray, L.H. Phillips, J.D. Sedgwick,
and L.L. Lanier. 2000. DAP12-deficient mice fail to develop
autoimmunity due to impaired antigen priming. Immunity.
13:345–353.
23. Eberl, G., H.J. Fehling, H. von Boehmer, and H.R. Mac-
Donald. 1999. Absolute requirement for the pre-T cell re-
ceptor alpha chain during NK1.1 TCRalphabeta cell de-
velopment. Eur. J. Immunol. 29:1966–1971.
24. Benlagha, K., A. Weiss, A. Beavis, L. Teyton, and A. Ben-
delac. 2000. In vivo identification of glycolipid antigen-spe-
cific T cells using fluorescent CD1d tetramers. J. Exp. Med.
191:1895–1903.
25. Benlagha, K., T. Kyin, A. Beavis, L. Teyton, and A. Ben-
delac. 2002. A thymic precursor to the NK T cell lineage.
Science. 296:553–555.
26. Pellicci, D.G., K.J. Hammond, A.P. Uldrich, A.G. Baxter,
M.J. Smyth, and D.I. Godfrey. 2002. A natural killer T
(NKT) cell developmental pathway involving a thymus-
dependent NK1.1(-)CD4() CD1d-dependent precursor
stage. J. Exp. Med. 195:835–844.
27. Gadue, P., and P.L. Stein. 2002. NK T cell precursors exhibit
differential cytokine regulation and require itk for efficient
maturation. J. Immunol. 169:2397–2406.
28. Gapin, L., J.L. Matsuda, C.D. Surh, and M. Kronenberg.
2001. NKT cells derive from double-positive thymocytes
that are positively selected by CD1d. Nat. Immunol. 2:971–
978.
29. Oberg, L., M. Eriksson, L. Fahlen, and C.L. Sentman. 2000.
Expression of Ly49A on T cells alters the threshold for T cell
responses. Eur. J. Immunol. 30:2849–2856.
30. Kim, S., K. Iizuka, H.S. Kang, A. Dokun, A.R. French, S.
Greco, and W.M. Yokoyama. 2002. In vivo developmental
stages in murine natural killer cell maturation. Nat. Immunol.
3:523–528.
 o
n
 July 22, 2008 
w
w
w
.jem.org
D
ow
nloaded from
 
 Published April 7, 2003
